Skip to main content
Premium Trial:

Request an Annual Quote

In Print: Last Week's Microarray Papers of Note: Jan 28, 2014


Coverage and efficiency in current SNP chips.
Eur J Hum Genet. 2014 Jan 22. doi: 10.1038/ejhg.2013.304. [Epub ahead of print]
Ha NT, et al.

To answer the question as to which commercial high-density SNP chip covers most of the human genome given a fixed budget, the authors compared the performance of 12 chips of different sizes released by Affymetrix and Illumina for the European, Asian, and African populations. They identified the Affymetrix population-optimized arrays as offering the most cost-effective coverage for Asian and African populations. For European populations, they established the Illumina HumanOmni2.5-8 BeadChip as the preferred choice. Coverage estimates calculated for all chips proved much lower than those advertised by the vendors.

Chromosomal microarray analysis allows prenatal detection of low-level mosaic autosomal aneuploidy.
Prenat Diagn. 2014 Jan 26. [Epub ahead of print]
Hall G, et al.

The authors found chromosomal microarray analysis to be effective in detecting low-level mosaic autosomal aneuploidy in a prenatal setting which traditional methods may fail to detect. They argue that this detection of low-level mosaicism supports the use of chromosomal microarray analysis in prenatal diagnosis.

Who are the Okinawans? Ancestry, genome diversity, and implications for the genetic study of human longevity from a geographically isolated population..
J Gerontol A Biol Sci Med Sci. 2014 Jan 20. [Epub ahead of print]
Bendjilali N, et al.

The authors used Affymetrix SNP chips to assess Okinawans, a population isolate, recognized for longevity. Okinawans clustered almost exclusively with East Asians, they found. Following a sibling relative risk analysis, they also determined that siblings of Okinawan centenarians have 3.11 times (females) and 3.77 times (males) more likelihood of centenarianism.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more